| Transaction Date | Recipient | Shares | Type | Price | Value |
|---|---|---|---|---|---|
| 3rd September 2020 | Randy Vandagriff | 6,410 | Exercise of derivative | $0.00 | |
| 3rd September 2020 | John G. O'Grady | 5,484 | Exercise of derivative | $0.00 | |
| 3rd September 2020 | John G. O'Grady | 1,660 | Payment by withholding | $6.46 | $10,723.60 |
| 3rd September 2020 | Eric Samuels | 4,273 | Exercise of derivative | $0.00 | |
| 3rd September 2020 | Terry R Taber | 7,692 | Exercise of derivative | $0.00 | |
| 3rd September 2020 | Eric Samuels | 1,414 | Payment by withholding | $6.46 | $9,134.44 |
| 3rd September 2020 | John G. O'Grady | 3,238 | Payment by withholding | $6.46 | $20,917.48 |
| 3rd September 2020 | John G. O'Grady | 10,683 | Exercise of derivative | $0.00 | |
| 3rd September 2020 | Randy Vandagriff | 1,879 | Payment by withholding | $6.46 | $12,138.34 |
| 3rd September 2020 | Terry R Taber | 2,571 | Payment by withholding | $6.46 | $16,608.66 |
Eastman Kodak Co
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 3/10.
Ticker: EK
Sector: Unknown
Industry: Unknown
SEC Central Index Key (CIK): 31235
Employees:
Exchange: None
Auditor Opinion:
You must Login to see Language Changes
Disclosure Language changes
You must Login to see analysis
Red Flags
Restructuring Charges of $1 M for the period Apr 2020 to Jun 2020 in the context of all up
Restructuring Charges of $8 M for the period Jan 2020 to Jun 2020 in the context of all up
Restructuring Charges of $2 M for the period Apr 2019 to Jun 2019 in the context of all up
Restructuring Charges of $4 M for the period Jan 2019 to Jun 2019 in the context of all up
Goodwill Impairment Loss of $0 for the period Jan 2020 to Jun 2020 in the context of all up
Goodwill Impairment Loss of $0 for the period Jan 2020 to Mar 2020 in the context of all up
Fundamentals
News
Meet the Schwab Foundation's 2020 Social Innovators of the Year
26th September 2020
Some 3,500 US companies sue over Trump-imposed Chinese tariffs
25th September 2020
Neiman Marcus emerges from bankruptcy
25th September 2020
Jyseleca® (Filgotinib) Approved in Japan for Rheumatoid Arthritis
25th September 2020